About HIRF
  1. Mission
  2. Management
  3. History
  4. Affiliates

About ICVS

  • 2001 Tokyo
  • 2003 Beijing
  • 2004 London
  • 2006 Washington DC
  • 2007 Vienna
  • 2008 New York
Grant Programs
  • Clinical Trials
  • Education
  • Training
  • Publication

Recommended Links

Contact HIRF

International Cancer Vaccine Symposium in Beijing 2003

International Cancer Vaccine Symposium: Beijing-China-2003
February 23 - 25, 2003 Tianlun Dynasty Hotel

Day 1: Sunday February 23, 2003

  1. Welcome Reception

Day 2: Monday February 24, 2003

08:30 Welcome & Opening Remarks:
  • Dr. Lowell T. HARMISON, Symposium Chairman
  • Dr. Jiefu HUANG, Vice Minister of Public Health, China
  • Dr. Depei LIU, President, Chinese Academy of Medical Sciences, China
  • Dr. Ping ZHAO, Director, Cancer Institute/Hospital, CAMS, China
  • Dr. Kenichiro HASUMI, Chairman, Hasumi Foundation, USA
09:10 Keynote Presentation:
  • Dr. Hans WIGZELL, Principal, Karolinska Institute, Stockholm, Sweden
  • gHow to Use the Immune System to Selectively Destroy Self Tissuesh
10:30 1st Session:
  • Dr. Dean L. MANN, University of Maryland, Baltimore, USA
    gArming Dendritic Cells for Delivery of Cancer Vaccinesh
  • Dr. Xue-tao CAO, Second Military Medical University, Shanghai, China
    gCancer Immunotherapy by Directed Chemo-attraction of Dendritic Cell and T Cellsh

12:30 Buffet-Lunch (All the Symposium Participants Are Invited)

13:30 2nd Session:
  • Dr. Georg STINGL, University of Vienna Medical School, Vienna Austria
    gCutaneous and Non-Cutaneous Dendritic cells as Targets of Cancer Vaccinesh
  • Dr. Wei-feng CHEN, Peking University, Beijing, China
    gImmune Response of Hepatocellular Carcinoma Patients to Tumor Antigensh
  • Dr. Bruce G. REDMAN, University of Michigan Comprehensive Cancer Center, Michigan, USA
    gStrategies to Improve Dendritic Cell Based Vaccinesh

16:50 Panel Discussion:

  1. Evening Social Buffet at Tianlun Dynasty Hotel
    ¦ All the Symposium Participants Invited

Day 3: Tuesday February 25, 2003

08:30 3rd Session:
  • Dr. Jeffrey S. WEBER, USC/Norris Comprehensive Cancer Center, USA
    gAntigen-Specific Approaches for Developing Melanoma Vaccinesh
  • Dr. Daiming FAN, Institute of Digestive Diseases, Xijing Hospital, Xian, China
    gIdentification and Clinical Application of Gastric Carcinoma Associated Antigensh
10:50 4th Session:
  • Dr. Gustav GAUDERNACK, The Norwegian Radium Hospital, Oslo, Norway
    gClinical Trials of Cancer Vaccines Targeting Telomeraseh
11:50 Buffet-Lunch (All the Symposium Participants Are Invited) 12:50 5th Session:
  • Dr. John T. SCHILLER, Laboratory of Cellular Oncology, National Cancer Institute, National Institute of Health, USA
    gHPV Vaccines Against Cervical Cancerh
  • Dr. Zongtang SUN, National Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences, Beijing, China
    gCancer Vaccines Against Human Hepatocarcinogensish
15:10 Panel Discussion with Special Presentation:
  • All The Guest Speakers
    gRegulatory & Scientific Issues of IND Application for Cancer Vaccine and Cancer Immunotherapyh
  • Dr. Robert E. WINDOM
    gInternational Aspect of Health and Cancerh

17:10 Symposium End Summary

End 17:30